Taken together, our results demonstrate that the novel MIR20B targets PPARA, plays a significant role in hepatic lipid metabolism, and present an opportunity for the development of novel therapeutics for NAFLD. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.